Australia's Nyrada jumps on Europe patent for cholesterol drug

Nyrada

17/05/2022 04:28

** Shares of drug developer  NYR.AX  leap as much as 16.7%
to A$0.193, their highest level since April 27
    ** Says the European Patent Office plans to grant Nyrada a
patent application for its cholesterol-lowering drug
 urn:newsml:reuters.com:*:nASXcgCySB 
    ** Patent to protect Nyrada's technology until 2038 
    ** Patent expected to be granted pending some final
administrative steps 
    ** NYR posts its best intraday gain since April 27 
    ** Stock down 31.3% this year, as of last close 
    


 (Reporting by Harshita Swaminathan in Bengaluru)
 ((Harshita.Swaminathan@thomsonreuters.com))